Skip to content
Directory

Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.
Filtered (10)
Filtered (10)
Filter

Filter

10 directory found

Type
See more See less
Species
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
Product Family
See more See less
Regulatory Status
See more See less
Region / Availability
See more See less
Search
Apply(10) Reset
Show (10)
Cancel
Apply(10) Reset
10 entriesShowing 1–10
Veterinarian reviewing a molecular target concept and an unbranded oral medicine with a dog caregiverNamed profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.
Palladia / Toceranib · Prescription Drug · Targeted Therapy · Palladia · Dogs · After Targeted Therapy · During Targeted Therapy

Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy

Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…

Read more
Veterinarian reviewing a molecular target concept and an unbranded oral medicine with a dog caregiverNamed profile Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine LymphomaRepresentative category illustration – no product packaging is shown.
Laverdia / Verdinexor · Prescription Drug · Targeted Therapy · Laverdia · Dogs · After Targeted Therapy · During Targeted Therapy

Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine Lymphoma

Verdinexor is an oral prescription antineoplastic for certain dogs with lymphoma. FDA announced full approval in January 2026 after the product's earlier conditional-approval pathway; publication should use the…

Read more
Calm dog receiving a monitored intravenous treatment in a veterinary clinicNamed profile Tanovea (Rabacfosadine): FDA-Approved Injectable Canine Lymphoma TherapyRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Tanovea · Dogs · After Chemotherapy · Before Chemotherapy

Tanovea (Rabacfosadine): FDA-Approved Injectable Canine Lymphoma Therapy

Rabacfosadine is a canine lymphoma drug whose current official label, patient selection, cumulative risks, and availability must be verified before use.

Read more
Veterinarian reviewing an immune pathway concept and an unbranded biologic treatment with a dog caregiverNamed profile Oncept Canine Melanoma Vaccine, DNA: USDA-Licensed Therapeutic BiologicRepresentative category illustration – no product packaging is shown.
Immunotherapy · Oncept · Dogs · After Targeted Therapy · Before Targeted Therapy · During Targeted Therapy · Manufacturer Information

Oncept Canine Melanoma Vaccine, DNA: USDA-Licensed Therapeutic Biologic

Oncept is a USDA-listed canine melanoma DNA biologic; license status, specialist access, intended setting, evidence limitations, and cost require current review.

Read more
Veterinary team coordinating a medication schedule for a dogNamed profile Stelfonta (Tigilanol Tiglate): Intratumoral Canine Mast Cell Tumor TherapyRepresentative category illustration – no product packaging is shown.
Prescription Drug · Targeted Therapy · Stelfonta · Dogs · After Targeted Therapy · During Targeted Therapy · Published Study

Stelfonta (Tigilanol Tiglate): Intratumoral Canine Mast Cell Tumor Therapy

Stelfonta is an FDA-approved intratumoral treatment for narrowly defined canine mast cell tumors, with important current warnings about degranulation, wounds, pain, tissue loss, amputation, and death.

Read more
Veterinarian reviewing an immune pathway concept and an unbranded biologic treatment with a dog caregiverNamed profile Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence ProfileRepresentative category illustration – no product packaging is shown.
Immunotherapy · Prescription Drug · Gilvetmab · Dogs · During Targeted Therapy · New Diagnosis · Published Study

Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence Profile

gilvetmab is covered as caninized anti-pd-1 monoclonal antibody immune-checkpoint inhibitor, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian reviewing hydration and digestive symptom monitoring with a dog caregiverNamed profile Canalevia-CA1 (Crofelemer): Chemotherapy-Induced Diarrhoea SupportRepresentative category illustration – no product packaging is shown.
Prescription Drug · Supportive-care medicine · Canalevia-CA1 · Dogs · After Chemotherapy · During Chemotherapy · Published Study

Canalevia-CA1 (Crofelemer): Chemotherapy-Induced Diarrhoea Support

crofelemer delayed-release tablets is covered as prescription antisecretory gastrointestinal medicine; supportive care, not antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian assessing comfort and mobility with a calm dog and caregiverNamed profile Bedinvetmab (Librela): Canine Osteoarthritis Pain Support in OncologyRepresentative category illustration – no product packaging is shown.
Pain Medication · Supportive-care medicine · Anti-NGF monoclonal antibodies · Dogs · Long-term Management · Palliative / Comfort Care · Published Study

Bedinvetmab (Librela): Canine Osteoarthritis Pain Support in Oncology

bedinvetmab is covered as canine monoclonal-antibody analgesic for osteoarthritis pain; not an antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian assessing comfort and mobility with a calm dog and caregiverNamed profile Frunevetmab (Solensia): Feline Osteoarthritis Pain Support in OncologyRepresentative category illustration – no product packaging is shown.
Pain Medication · Supportive-care medicine · Anti-NGF monoclonal antibodies · Cats · Long-term Management · Palliative / Comfort Care · Published Study

Frunevetmab (Solensia): Feline Osteoarthritis Pain Support in Oncology

frunevetmab is covered as feline monoclonal-antibody analgesic for osteoarthritis pain; not an antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Caregiver and veterinary professional reviewing symptom observations for a dogNamed profile H1 and H2 Blockade Around Mast-Cell Degranulation RiskRepresentative category illustration – no product packaging is shown.
Prescription Drug · Supportive-care medicine · Mast-cell mediator blockade · Dogs · During Targeted Therapy · Veterinary Clinical Use · Label-linked companion-medication context

H1 and H2 Blockade Around Mast-Cell Degranulation Risk

H1-receptor and H2-receptor blocking companion medicines is covered as protocol-linked supportive medicines; not direct antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led…

Read more